Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) traded up 7% during mid-day trading on Friday . The stock traded as high as $186.60 and last traded at $186.7340. 2,624,011 shares changed hands during trading, a decline of 46% from the average session volume of 4,833,689 shares. The stock had previously closed at $174.45.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on ALAB shares. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Raymond James Financial began coverage on shares of Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating on the stock. Cowen reissued a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Stifel Nicolaus upped their price objective on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, TD Cowen lowered their target price on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research note on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.
Check Out Our Latest Stock Report on Astera Labs
Astera Labs Stock Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period last year, the firm posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other news, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the sale, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 576,936 shares of company stock valued at $87,409,540. 12.50% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Cherry Creek Investment Advisors Inc. grew its position in shares of Astera Labs by 5.5% in the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 3,854 shares of the company’s stock worth $641,000 after buying an additional 200 shares during the last quarter. Nisa Investment Advisors LLC raised its holdings in Astera Labs by 30.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 7,794 shares of the company’s stock worth $1,297,000 after purchasing an additional 1,819 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in Astera Labs by 25.2% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 554,444 shares of the company’s stock valued at $99,556,000 after buying an additional 111,502 shares during the period. MOR Wealth Management LLC bought a new stake in shares of Astera Labs during the 4th quarter valued at $294,000. Finally, Redhawk Wealth Advisors Inc. bought a new position in shares of Astera Labs in the 4th quarter worth about $246,000. Institutional investors own 60.47% of the company’s stock.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- Trump’s crypto czar leaked THIS
- NEW LAW: Congress Approves Setup For Digital Dollar?
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The Crash Has Already Started (Most Just Don’t See It Yet)
- A month before the crash
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
